Valuation : Anpario plc

Market Cap 93.06M 126M 108M 103M 175M 12.02B 175M 1.22B 469M 6.12B 473M 462M 19.33B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 80.38M 109M 93.65M 88.68M 151M 10.38B 152M 1.05B 405M 5.28B 408M 399M 16.69B EV / Sales 2026 *
1.65x
EV / Sales 2027 * 1.47x
Free-Float
71.2%
Yield 2026 *
2.87%
Yield 2027 * 2.95%
1 day-2.65%
1 week-14.02%
Current month-14.18%
1 month-9.80%
3 months-11.54%
Current year-3.16%
1 week 455.1
Extreme 455.1
555
1 month 455.1
Extreme 455.1
555
Current year 391.11
Extreme 391.11
580
1 year 391.11
Extreme 391.11
580
3 years 215
Extreme 215
580
5 years 177
Extreme 177
710
10 years 177
Extreme 177
729.6
Manager TitleAgeSince
Chief Executive Officer 61 12/01/2016
Director of Finance/CFO - 30/06/2021
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 61 30/11/2006
Director/Board Member 66 30/09/2009
Chairman 67 28/06/2023
Date Insider Type Main position Quantity % Market Cap. Importance
02/04/25 Buy

Chief Financial Officer

3,778 0.0185%
02/04/25 Buy

Chief Financial Officer

5,010 0.0245%
02/04/25 Sell

Chief Financial Officer

7,621 0.0373%
Change 5-day change 1-year change 3-year change Capi.($)
-2.65%-14.02%-6.12%+102.20% 126M
-0.81%-4.19%-34.23%-12.09% 10.47B
-1.18%-2.34%-27.41%-35.40% 5.02B
-3.66%-1.56%-32.77%-36.67% 2.95B
-0.76%+0.38%+30.51%+62.44% 2.74B
-1.75%-2.60%-21.81%-49.40% 2.15B
-0.96%-5.79%-43.72%-64.28% 1.26B
-1.99%-0.03%+11.80%+86.00% 1.14B
-4.11%+1.76%-17.02%-17.41% 915M
-1.02%+0.75%-23.18%-24.72% 868M
Average -1.89%-4.04%-16.39%+1.07% 2.76B
Weighted average by Cap. -1.43%-3.01%-22.94%-12.85%

Financials

2026 *2027 *
Net sales 48.85M 66.07M 56.92M 53.9M 91.65M 6.31B 92.11M 640M 246M 3.21B 248M 243M 10.15B 51.14M 69.17M 59.59M 56.43M 95.95M 6.61B 96.44M 670M 258M 3.36B 260M 254M 10.62B
Net income - -
Net Debt -12.68M -17.15M -14.78M -13.99M -23.79M -1.64B -23.91M -166M -63.9M -834M -64.41M -63M -2.63B -17.93M -24.24M -20.89M -19.78M -33.63M -2.32B -33.8M -235M -90.33M -1.18B -91.05M -89.05M -3.72B
Logo Anpario plc
Anpario plc is a United Kingdom-based independent manufacturer of natural sustainable feed additives for animal health, nutrition and biosecurity. The Company’s addictive solutions include poultry, ruminant, swine, aqua and feed mill. Its product categories include health & performance, toxin management, feed quality, and hygiene & insect control. Its health & performance products include Orego-Stim Range, Orego-Stim Range (Aqua), pHorce Range, Salkil Range, Optomega Range and Genex Range. Its toxin management products include Anpro Range and Anpro Advance. Its feed quality products include pHorce Range, Salgard Range, Mastercube Range, Moldgard, Oxigard Range and Feedzyme Range. Its technologies are sold in over 80 countries through established sales and distribution networks, which include a number of wholly owned subsidiaries.
Employees
162
Date Price Change Volume
11/09/26 GBX 460.00 -2.65% 49,302
10/09/26 GBX 472.50 -1.56% 53,622
09/09/26 GBX 480.00 -11.93% 207,357
08/09/26 GBX 545.00 +1.87% 37,713
07/09/26 GBX 535.00 0.00% 7,461
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
4.600GBP
Average target price
6.130GBP
Spread / Average Target
+33.26%

Net sales - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!